MorphoSys AG Reports Results for the First Six Months of 2015
27 juil. 2015 01h04 HE
|
MorphoSys AG
MUNICH, Germany, July 27, 2015 (GLOBE NEWSWIRE) -- Therapeutic Pipeline Exceeds 100 Drug Candidates in Research & Development
Conference call (in English) today at 2:00pm CEST (1:00pm BST/8:00am...
MorphoSys Announces Clinical Milestone in Blood Disorders Program
23 juil. 2015 01h37 HE
|
MorphoSys AG
MARTINSRIED / MUNICH, Germany, July 23, 2015 (GLOBE NEWSWIRE) -- MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX, OTC: MPSYY) announced today that it has received a milestone payment from...
MorphoSys to Host Q2 2015 Conference Call on 27 July 2015
20 juil. 2015 08h07 HE
|
MorphoSys AG
MARTINSRIED / MUNICH, Germany, July 20, 2015 (GLOBE NEWSWIRE) -- MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX) will publish its first six months' 2015 results on 27 July 2015 at 7:00 am...
MorphoSys Presents Updated Phase 2 Clinical Results for MOR208 Monotherapy in NHL at ASCO Annual Meeting
01 juin 2015 11h05 HE
|
MorphoSys AG
MARTINSRIED / MUNICH, Germany, June 1, 2015 (GLOBE NEWSWIRE) -- MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX; OTC: MPSYY) today announced updated clinical data on its proprietary drug...
MorphoSys Presents First Safety, Pharmacokinetic and Efficacy Data for MOR202 in Multiple Myeloma at ASCO Meeting
31 mai 2015 09h27 HE
|
MorphoSys AG
Clinical Activity and Long-lasting Tumor Control Already Observed at Low Doses
MOR202 is safe and tolerable in weekly and biweekly doses
MOR202 showed early signs of clinical activity...
MorphoSys to Present at Five Upcoming Conferences
29 mai 2015 08h07 HE
|
MorphoSys AG
MARTINSRIED / MUNICH, Germany, May 29, 2015 (GLOBE NEWSWIRE) -- MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX; OTC: MPSYY) will present at the following conferences:
ASCO (American Society...
MorphoSys to Present Data on Proprietary Programs at 20th Congress of the European Hematology Association
21 mai 2015 11h06 HE
|
MorphoSys AG
MARTINSRIED / MUNICH, Germany, May 21, 2015 (GLOBE NEWSWIRE) -- MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX) today announced the publication of three MorphoSys abstracts which were...
MorphoSys to Present Data on Proprietary Programs at American Society of Clinical Oncology Annual Meeting
13 mai 2015 17h35 HE
|
MorphoSys AG
MARTINSRIED / MUNICH, Germany, May 13, 2015 (GLOBE NEWSWIRE) -- MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX) today announced the publication of three MorphoSys abstracts which were...
MorphoSys to Present at Two Upcoming Investor Conferences
12 mai 2015 11h15 HE
|
MorphoSys AG
Martinsried / Munich, Germany, May 12, 2015 (GLOBE NEWSWIRE) -- MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX; OTC: MPSYY) will present at the following investor conferences in May:
BofAML...
Annual General Meeting of MorphoSys AG Elects New Supervisory Board Members
08 mai 2015 09h55 HE
|
MorphoSys AG
Martinsried / Munich, Germany, May 8, 2015 (GLOBE NEWSWIRE) -- MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX) announced today that its shareholders elected Ms. Wendy Johnson, Mr. Klaus...